2022 Focus Areas


The key focus areas for 2022 are:


  • Novel Methodologies to Enhance Global Ophthalmic Clinical Insights, with emphasis on:
    • Remote data collection strategies for intercontinental and local assessment of clinical contact lens performance and related ocular physiology


  • New Technologies for Prediction, Prevention, and Treatment of Myopia, including:
    • Novel ways of collecting information about the visual environment
    • Myopia control modalities and quality of life / visual efficiency measurements
    • Ortho-K applications for Myopia management
    • Applications of Digital Therapeutics for Myopia 
    • Intelligent systems (machine learning) and big data approaches for identifying eyes at risk of developing pathology due to refractive error



Award Types

Research proposals may span proof-of-concept through translational stages. For this purpose, two types of awards are offered:

CooperVision Seedling Award
The CooperVision Seedling Award is intended to incentivize collaborations with CooperVision in a new research area for a one-year period. The maximum total cash amount for a CooperVision seedling is $100,000.

CooperVision Translational Research Award
The CooperVision Translational Research Award is a multi-year award for a substantive translational research project with funding over two years, totaling up to $400,000.


Applicant Eligibility


Any researcher with Principal Investigator (PI) status holding a MD, OD, or PhD is eligible to apply. Applicants, such as postdoctoral fellows, with a waiver of PI status must submit appropriate documentation before funding can be received.


To Apply

Submission of a Letter of Intent (LOI)

Applicants must submit a LOI before July 15, 2022.  If the LOI is accepted, applicants will be notified and invited to submit a full proposal.

Proposal Submission
Upon approval of the LOI, applicants may submit a full proposal. The complete proposal must be submitted by the deadline September 30, 2022.

Please note that animal model proposal studies will not be accepted for 2022 Science & Technology Awards


Please contact STAward@coopervision.com with questions.


CooperVision will make an effort to limit access to the LOIs and full proposals to CooperVision employees involved in implementing the Science & Technology Award.  However, due to the numbers received, CooperVision will not enter into a confidentiality agreement as a condition for receipt of a LOI or full proposal.   Therefore, applicants should take care to exclude confidential information from their submissions.  


Programs